|
The majority of emerging infectious diseases are of zoonotic origin
(i.e., transmissible between humans and animals causing infection in both species).
Many of the most dangerous and easily transmitted of these agents are viruses.
The majority of the emerging or re-emerging human viruses lack an effective vaccine or anti-viral drug treatment.
The recent emergence of the highly pathogenic avian influenza virus H5N1 emphasizes this unmet need.
Recent advances in basic and applied research have provided an unparalleled opportunity to understand
the interplay between the virus, the host, and the immune system, particularly on matters of immune cells
and molecules involved in the generation of immunity, effector mechanisms, and mechanisms involved in the
generation and maintenance of immune memory responses. This meeting will assemble basic and applied
viral immunologists from academia, government, and industry to foster effective translation of new
findings in basic research into effective vaccines and therapies. The goal of the meeting is to accelerate
anti-viral vaccine and therapeutic development, to facilitate a rapid response to the threat of emerging
viruses, with the focus of the meeting centered on influenza viruses.
Plenary Lecture by Peter C. Doherty
1996 Nobel Laureate in Physiology or Medicine
"The relationship between influenza primary and memory CD8 T cell responses and novel developments in CD8 T cell vaccine design for influenza virus"
Download a meeting flyer
|
